"Coach" "models/weapons/arms/v_arms_coach_new.mdl" "Mechanic" "models/weapons/arms/v_arms_mechanic_new.mdl" "Producer" "models/weapons/arms/v_arms_producer_new.mdl ...

U.S. officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

The FDA approved Journavx, the first new pain medication in over 20 years, as a non-opioid alternative for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill ...

The long quest for powerful non-opioid drugs that treat pain without risk of addiction is nearing a milestone, in the form of a pill that could soon win approval from the Food and Drug Administration.

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin ...

The FDA approved Journavx, the first new pain medication in over 20 years, as a non-opioid alternative for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals before ...

In a significant development, federal officials have approved a new pain management medication, Journavx, aiming to mitigate the risks associated with opioid use, such as addiction and overdose. The U ...